Latest news with #MarshallWhite
Yahoo
07-07-2025
- Business
- Yahoo
TEAM Technologies, an Arlington Capital Partners Portfolio Company, Expands Medical Device Manufacturing Capabilities with Acquisition of Duke Empirical, Inc.
WASHINGTON & KNOXVILLE, Tenn., July 07, 2025--(BUSINESS WIRE)--Arlington Capital Partners ("Arlington"), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced that its portfolio company TEAM Technologies ("TEAM Tech"), a leading end-to-end outsourced manufacturer of mission-critical medical devices, has acquired another leader in the sector, Duke Empirical, Inc ("Duke"). Based in Morgan Hill, CA., Duke is a leading designer, developer and manufacturer of advanced medical devices for interventional cardiovascular applications. Duke specializes in the design and manufacture of innovative catheters and minimally invasive delivery systems. TEAM Tech works with blue-chip healthcare customers and medical device OEMs to provide end-to-end outsourced design and manufacturing services for critical medical devices, enabling customers to streamline their supply chains and reduce delivery lead times. With synergistic production capabilities and customer bases, the acquisition of Duke will further complement TEAM's turnkey offering for healthcare and MedTech OEMs, enabling accelerated manufacturing at scale for complex Class II / III medical devices and delivery systems. "Our investment in TEAM Tech reflects Arlington's focus on building businesses that deliver mission critical solutions in complex, regulated end markets. The addition of Duke expands TEAM Tech's ability to serve leading healthcare and MedTech OEMs in the fastest growing segments of the medical device market, while enhancing its capabilities to develop and manufacture highly advanced devices that support the delivery of life saving medical procedures," said Matt Altman, a Managing Partner at Arlington Capital Partners. "When we began our partnership with Arlington, we knew we had an opportunity to accelerate our growth and expand our offerings to best serve our clients," said Marshall White, President and CEO of TEAM Tech. "Duke adds complementary capabilities and greater capacity to our already robust portfolio of full-service medical device manufacturing solutions, and will enable us to provide a greater breadth of complete solutions for our customer partners, who are doing critical, lifesaving work across the healthcare field." "The acquisition of Duke enhances TEAM Tech's capabilities by furthering its expertise in designing and manufacturing advanced interventional cardiovascular products as well as polymer extrusion," said Gordon Auduong, Managing Director at Arlington Capital Partners. "We are excited to partner with the exceptional team at Duke to deliver TEAM Tech's entire portfolio of capabilities to further support our customers' growth." Arlington has an extensive track record of building leading companies in highly regulated industries that are critical to the USA's healthcare infrastructure, government systems and national security. Within healthcare, Arlington focuses on working with businesses that save lives, improve the delivery of products and services and reduce costs for patients and providers. Other notable recent healthcare sector investments the firm has made include Riverpoint Medical, Millstone Medical Outsourcing, Grand River Aseptic Manufacturing, Everest Clinical Research, Afton Scientific and AVS Bio. Houlihan Lokey served as financial advisor and Goodwin Procter LLP served as legal advisor to TEAM Tech and Arlington Capital Partners. About Arlington Capital Partners Arlington Capital Partners is a Washington, D.C.-area private investment firm specializing in government-regulated industries. The firm partners with founders and management teams to build strategically important businesses in the healthcare, government services and technology, and aerospace and defense sectors. Since its inception in 1999, Arlington has invested in over 175 companies and is currently investing out of its $3.8 billion Fund VI. For more information, visit Arlington's website at and follow Arlington on LinkedIn. About TEAM Technologies Headquartered in Knoxville, TN, with facilities throughout the United States and international facilities in Mexico and Singapore, TEAM Technologies is a specialized end-to-end outsourced manufacturer of mission-critical, single-use medical devices. The company has an extensive array of advanced and vertically integrated manufacturing solutions servicing top medical device and pharmaceutical OEMs. With its deep industry experience and reputation for the highest quality standards, TEAM Technologies leverages seamless, turnkey processes and innovation to dramatically simplify and improve its customers' supply chains. For more information, visit About Duke Empirical, Inc. Headquartered in Morgan Hill, CA, Duke Empirical is a leading developer and manufacturer of innovative medical devices focused on advanced catheters and minimally invasive delivery systems. The company specializes in medical device design and development, precision custom extrusion, high performance catheter manufacturing, medical device component assembly, and finished goods assembly and packaging. For more information, visit View source version on Contacts Media Contact Ryan FitzGibbonPro-arlington@ 登入存取你的投資組合
Business Wire
07-07-2025
- Business
- Business Wire
TEAM Technologies, an Arlington Capital Partners Portfolio Company, Expands Medical Device Manufacturing Capabilities with Acquisition of Duke Empirical, Inc.
WASHINGTON & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Arlington Capital Partners ('Arlington'), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced that its portfolio company TEAM Technologies ('TEAM Tech'), a leading end-to-end outsourced manufacturer of mission-critical medical devices, has acquired another leader in the sector, Duke Empirical, Inc ('Duke'). Based in Morgan Hill, CA., Duke is a leading designer, developer and manufacturer of advanced medical devices for interventional cardiovascular applications. Duke specializes in the design and manufacture of innovative catheters and minimally invasive delivery systems. TEAM Tech works with blue-chip healthcare customers and medical device OEMs to provide end-to-end outsourced design and manufacturing services for critical medical devices, enabling customers to streamline their supply chains and reduce delivery lead times. With synergistic production capabilities and customer bases, the acquisition of Duke will further complement TEAM's turnkey offering for healthcare and MedTech OEMs, enabling accelerated manufacturing at scale for complex Class II / III medical devices and delivery systems. 'Our investment in TEAM Tech reflects Arlington's focus on building businesses that deliver mission critical solutions in complex, regulated end markets. The addition of Duke expands TEAM Tech's ability to serve leading healthcare and MedTech OEMs in the fastest growing segments of the medical device market, while enhancing its capabilities to develop and manufacture highly advanced devices that support the delivery of life saving medical procedures,' said Matt Altman, a Managing Partner at Arlington Capital Partners. 'When we began our partnership with Arlington, we knew we had an opportunity to accelerate our growth and expand our offerings to best serve our clients,' said Marshall White, President and CEO of TEAM Tech. 'Duke adds complementary capabilities and greater capacity to our already robust portfolio of full-service medical device manufacturing solutions, and will enable us to provide a greater breadth of complete solutions for our customer partners, who are doing critical, lifesaving work across the healthcare field.' 'The acquisition of Duke enhances TEAM Tech's capabilities by furthering its expertise in designing and manufacturing advanced interventional cardiovascular products as well as polymer extrusion,' said Gordon Auduong, Managing Director at Arlington Capital Partners. 'We are excited to partner with the exceptional team at Duke to deliver TEAM Tech's entire portfolio of capabilities to further support our customers' growth.' Arlington has an extensive track record of building leading companies in highly regulated industries that are critical to the USA's healthcare infrastructure, government systems and national security. Within healthcare, Arlington focuses on working with businesses that save lives, improve the delivery of products and services and reduce costs for patients and providers. Other notable recent healthcare sector investments the firm has made include Riverpoint Medical, Millstone Medical Outsourcing, Grand River Aseptic Manufacturing, Everest Clinical Research, Afton Scientific and AVS Bio. Houlihan Lokey served as financial advisor and Goodwin Procter LLP served as legal advisor to TEAM Tech and Arlington Capital Partners. About Arlington Capital Partners Arlington Capital Partners is a Washington, D.C.-area private investment firm specializing in government-regulated industries. The firm partners with founders and management teams to build strategically important businesses in the healthcare, government services and technology, and aerospace and defense sectors. Since its inception in 1999, Arlington has invested in over 175 companies and is currently investing out of its $3.8 billion Fund VI. For more information, visit Arlington's website at and follow Arlington on LinkedIn. About TEAM Technologies Headquartered in Knoxville, TN, with facilities throughout the United States and international facilities in Mexico and Singapore, TEAM Technologies is a specialized end-to-end outsourced manufacturer of mission-critical, single-use medical devices. The company has an extensive array of advanced and vertically integrated manufacturing solutions servicing top medical device and pharmaceutical OEMs. With its deep industry experience and reputation for the highest quality standards, TEAM Technologies leverages seamless, turnkey processes and innovation to dramatically simplify and improve its customers' supply chains. For more information, visit About Duke Empirical, Inc. Headquartered in Morgan Hill, CA, Duke Empirical is a leading developer and manufacturer of innovative medical devices focused on advanced catheters and minimally invasive delivery systems. The company specializes in medical device design and development, precision custom extrusion, high performance catheter manufacturing, medical device component assembly, and finished goods assembly and packaging. For more information, visit
7NEWS
07-07-2025
- Business
- 7NEWS
Busy roads and small spaces don't stop auction prices soaring
In an unorthodox morning of bidding, a Fairlight auction packed out the Cunninghams office to compete for a home on busy Sydney Road. On the National front, auction activity eased last week, with 1,786 homes taken to auction across the country, the lowest number since the King's Birthday long weekend four weeks ago. While volumes were down, this figure remained slightly above the same time last year, when 1,776 homes were brought to market. Despite the dip in activity, the preliminary clearance rate held firm at 73.1 percent, slightly down from 74.5 percent the week prior. That earlier figure was later revised to 67.9 percent, which still marked the highest final clearance rate recorded since March. Encouragingly, the preliminary clearance rate has remained above the 70 percent mark for four consecutive weeks and in eight of the past ten. Melbourne led the nation in volume, with 756 homes going under the hammer, a significant drop from 962 auctions the week before. So far, 75.5 percent of reported Melbourne auctions have been successful, edging up from 75.2 percent the previous week, which was later revised to 68.2 percent. The city has now maintained a preliminary clearance rate above 75 percent for three straight weeks. Sydney followed with 691 auctions, down from 771 the previous week. Its preliminary clearance rate slipped to 72.5 percent, one percentage point below the week prior, with final figures likely to be revised similarly to previous weeks. Among the smaller capitals, Brisbane led with 155 auctions and a 70.8 percent preliminary clearance rate. Adelaide recorded 102 auctions with a success rate of 65.7 percent, while the ACT saw 69 auctions and a strong 73.1 percent success rate, the territory's best result since mid-March. Auction volumes are expected to decline further, with around 1,445 homes currently scheduled for next week and approximately 1,500 the week after. Luxe, leafy, locked in. Toorak apartment fetches $1.73m in hotly contested auction A generously proportioned apartment in one of Toorak's most tightly held enclaves sold under the hammer on Saturday for $1.73 million, as competitive bidding reaffirmed buyer appetite for premium, house-sized apartments in boutique settings. Set amid lush north-facing gardens at 8/40 Lansell Road, the oversized three-bedroom, two-bathroom apartment impressed with its refined interiors, separate living and dining zones and expansive balcony designed for year-round entertaining. Positioned on the second floor of a rarely offered block, it offers scale, style and seclusion. David Stringer, listing agent at Marshall White, said the property attracted 50 groups during the campaign, with five bidders stepping forward on the day. "There was strong interest because it's hard to find apartments this size in such a quiet, private location," he said. "These types of properties always perform well, and this one didn't let down." Stringer described the auction as "spirited," noting that only two bidders were registered pre-auction, but more joined in as the momentum built. "This is the kind of place that works as a permanent home, a Melbourne base or a lock-up-and-leave. It really doesn't get much better than this on Lansell Road," he added. With features including a designer kitchen, luxurious main suite, ducted heating, Versace tiling and two secure carports, the move-in-ready residence offered both immediate lifestyle appeal and long-term investment confidence. Packed office and happy tears as Fairlight townhouse commands $2.6m A sun-soaked Fairlight townhouse with sweeping views and serious family appeal has sold for $2.68 million after a dramatic auction that ended with hugs, happy tears and exchanged phone numbers. Set in a boutique block of six at 1/190 Sydney Road, the four-bedroom residence blends house-like proportions with easy Northern Beaches living. Landscaped gardens and a gated courtyard provide a peaceful welcome, while two north-facing terraces capture sweeping views from Seaforth to Collaroy Plateau. Georgie Bates of Cunninghams said the campaign drew strong crowds, with buyers loving the sunny terraces, solid build and flexible tri-level floor plan. Despite only two registered bidders, the auction delivered drama. The owners moved it from the property site to Cunninghams' Balgowlah office to avoid the noise of Sydney Road. The office quickly filled with bidders and their extended families, creating an unexpectedly intense setting. Bidding jumped in $10,000s, $20,000s and $40,000s. The underbidder shook his head four separate times, then stepped outside for a five-minute breather before finally conceding. The winning buyer, overcome with emotion, teared up and exchanged numbers with the sellers. "They're already talking about buying some of the furniture," Bates said. "They're thrilled and keen to renovate." Featuring a Bosch kitchen, double-glazed bedrooms, multiple living zones and a versatile lower-level retreat, the townhouse balances privacy, light and family function. "This kind of property rarely comes up," Bates said. "It has space, sun and a great community around it." When detail counts, 13 Gavin Street Warrnambool sets a new street record A crowd of 40 gathered to watch a tightly contested auction in Warrnambool on Saturday, where 13 Gavin Street sold under the hammer for $790,000, a new record for the street. Ray White listing agent Fergus Torpy said there was strong interest in the modern, renovated home throughout the campaign, culminating in three "solid bidders", all families, going head-to-head on auction day. "These were people genuinely looking for their forever home," Torpy said. "There wasn't a lot of showboating. It was a determined, respectful back-and-forth. Just really straightforward, steady bidding." Bidding opened at $750,000 and climbed in $5,000 and $10,000 increments with no pauses. In the end, it was a couple with deep ties to the neighbourhood who came out on top. "They were expats from the area who had grown up nearby and always wanted to come back," said Torpy. "So it wasn't just a property purchase for them. It was about coming home." Torpy said the sellers had put a huge amount of thought and detail into the renovation, and buyers could see that. "The house has that clean, modern look that people want, but it also has warmth and personality. It's not cookie-cutter," he said. "It just really resonated with the families who walked through." The result, he added, was no surprise. "It deserved to break the street record. The response from buyers backed that up."
AU Financial Review
04-07-2025
- Business
- AU Financial Review
Toorak wellness house sells with feng shui approval after asking $39m
A contemporary Toorak mansion designed to enhance the health and wellbeing of its inhabitants has sold in an international deal where numbers – including price and settlement dates – had to be approved by the vendor's Hong Kong-based feng shui master. To add another layer of complexity, the four parties involved in the deal were operating in different time zones. The vendors were in Hong Kong, the purchasers in London and one of the listing agents – Marshall White's Marcus Chiminello – was on Italy's Amalfi Coast. His co-listing agent, Sotheby's Rob Curtain, was the only member of the negotiation team in Australia at the time of the deal.
News.com.au
02-07-2025
- Business
- News.com.au
Rare Glen Iris sale tops weekend auction results
A grand Edwardian time capsule in Glen Iris has topped Melbourne's auction results for the week, selling for $3.45m in a tightly contested showdown. The home at 4 Dorrington Ave attracted a flurry of interest thanks to its unspoilt character, with competition ultimately pushing it above its revised $2.9m-$3.1m price hopes. Marshall White Stonnington's Mark Harris said the result reflected just how rare homes of this calibre were in the tightly held Dorrington Estate. 'We haven't seen an unrenovated period property like this come up in the area for decades,' Mr Harris said. 'The block, the mature trees, the craftsmanship, it had that sense of soul buyers are desperate for, and the opportunity to renovate and extend at the rear made it irresistible.' The property hadn't changed hands since 1973, marking the end of a 51-year chapter for its long-time custodians. Mr Harris said buyers were drawn to its authenticity, with original marble fireplaces, stained-glass windows, and decorative ceilings all intact, but crucially, not over-renovated. 'It had been updated in parts, like the kitchen and bathroom, but the heritage bones remained untouched,' he said. 'That gave buyers a clear vision of what it could become.' The eventual buyers plan to preserve the home's grand facade and renovate sensitively, something Mr Harris said meant the world to the outgoing owners. 'It was emotional, no doubt. But there was a deep sense of peace knowing the next family wanted to honour the home's story, not erase it.' The Glen Iris sale comes as demand for blue-chip period homes on large blocks continues to outstrip supply, with prestige buyers quick to act on listings with location, land and legacy. 'The prestige market is still strong, especially for homes with land, charm and potential,' Mr Harris said. 'And if the Reserve Bank moves on rate cuts, we'll likely see even more activity at this level.'
